Christopher John Swain

Person

Duxford, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Tetrahydropyran compounds as tachykinin antagonists
- Patent number 7,393,858
- Issue date Jul 1, 2008
- Merck Sharp & Dohme Ltd.
- Olivier Dirat
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Gem-disubstituted cyclohexane derivatives and their use as therapeu...
- Patent number 7,253,205
- Issue date Aug 7, 2007
- Merck Sharp & Dohme Limited
- Jose Luis Castro Pineiro
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclohexane derivatives and their use as therapeutic agents
- Patent number 7,105,507
- Issue date Sep 12, 2006
- Merck Sharp & Dohme Limited
- Jose Luis Castro Pineiro
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrahydrofuran derivatives and their use as NK-1 antagonists
- Patent number 6,964,981
- Issue date Nov 15, 2005
- Merck Sharp & Dohme Ltd.
- Brian John Williams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclohexyl derivatives and their use as therapeutic agents
- Patent number 6,953,792
- Issue date Oct 11, 2005
- Merck Sharp & Dohme Limited
- Jose Luis Castro Pineiro
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrahydropyran derivatives as neurokinin receptor antagonists
- Patent number 6,906,085
- Issue date Jun 14, 2005
- Merck Sharp & Dohme Ltd
- Jose Luis Castro Pineiro
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of NK-1 receptor antagonists for treating major depressive diso...
- Patent number 6,613,765
- Issue date Sep 2, 2003
- Merck Sharp & Dohme Limited
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tetrahydropyran derivatives and their use as therapeutic agents
- Patent number 6,489,343
- Issue date Dec 3, 2002
- Merck Sharp & Dohme Ltd.
- Jose Luis Castro Pineiro
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetrahydropyran derivatives and their use as therapeutic agents
- Patent number 6,458,830
- Issue date Oct 1, 2002
- Merck Sharp & Dohme Ltd.
- Simon Neil Owen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of NK-1 receptor antagonists for treating cognitive disorders
- Patent number 6,271,230
- Issue date Aug 7, 2001
- Merck Sharp & Dohme Limited
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spiro-azacyclic derivatives and their use as therapeutic agents
- Patent number 6,225,320
- Issue date May 1, 2001
- Merck Sharp & Dohme Ltd.
- Janusz Jozef Kulagowski
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiro-azacyclic derivatives and their use as therapeutic agents
- Patent number 6,172,077
- Issue date Jan 9, 2001
- Merck Sharp & Dohme Ltd.
- Neil Roy Curtis
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
1-piperidinyl-propan-2-derivatives and their use as therapeutic agents
- Patent number 6,136,824
- Issue date Oct 24, 2000
- Merck Sharp & Dohme Ltd.
- Angus Murray MacLeod
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiro-ketal derivatives and their use as therapeutic agents
- Patent number 6,127,365
- Issue date Oct 3, 2000
- Merck Sharp & Dohme Ltd.
- Jason Matthew Elliott
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of NK-1 receptor antagonists for treating major depressive diso...
- Patent number 6,114,315
- Issue date Sep 5, 2000
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptors antagonists for treating schizophrenic disorders
- Patent number 6,100,256
- Issue date Aug 8, 2000
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
3-benzylaminopiperidines as tachykinin receptor antagonists
- Patent number 6,096,766
- Issue date Aug 1, 2000
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of NK-1 receptor antagonists for treating amnestic disorders
- Patent number 6,096,729
- Issue date Aug 1, 2000
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating stress disorders
- Patent number 6,087,348
- Issue date Jul 11, 2000
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spiro-ketal derivatives and their use as therapeutic agents
- Patent number 6,080,740
- Issue date Jun 27, 2000
- Merck Sharp & Dohme Ltd.
- Jonathan David Moseley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiro-piperidine derivatives and their use as therapeutic agents
- Patent number 6,071,927
- Issue date Jun 6, 2000
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spiro-piperidine derivatives and their use as therapeutic agents
- Patent number 6,071,928
- Issue date Jun 6, 2000
- Merck Sharp & Dohme, Ltd.
- Neil Roy Curtis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spiro-piperidine derivatives and their use as tachykinin antagonists
- Patent number 6,060,469
- Issue date May 9, 2000
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiro-azacyclic derivatives, their preparation and their use as tac...
- Patent number 6,046,195
- Issue date Apr 4, 2000
- Merck Sharp & Dohme Ltd.
- Karen Elizabeth Haworth
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted morpholine derivative and its use as a therapeutic agent
- Patent number 5,985,874
- Issue date Nov 16, 1999
- Merck Sharp & Dohme Ltd.
- Simon Neil Owen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidine and morpholine derivatives and their use as therapeutic...
- Patent number 5,985,896
- Issue date Nov 16, 1999
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of NK-1 receptor antagonists for treating bipolar disorders
- Patent number 5,977,104
- Issue date Nov 2, 1999
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Morpholine derivatives and their use as therapeutic agents
- Patent number 5,968,934
- Issue date Oct 19, 1999
- Merck Sharp & Dohme Ltd.
- Christopher John Swain
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of NK-1 receptor antagonists for treating bipolar disorders
- Patent number 5,952,315
- Issue date Sep 14, 1999
- Merck Sharp & Dohme Ltd.
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of NK-1 receptor antagonists for treating sexual dysfunctions
- Patent number 5,929,054
- Issue date Jul 27, 1999
- Merck Sharp
- Raymond Baker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Tetrahydropyran compounds as tachykinin antagonists
- Publication number 20060172999
- Publication date Aug 3, 2006
- Olivier Dirat
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Gem-disubstituted cyclohexane derivatives and their use as therapeu...
- Publication number 20040171642
- Publication date Sep 2, 2004
- Jose Luis Castro Pineiro
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tetrahydropyran derivatives as neurokinin receptor antagonists
- Publication number 20040063974
- Publication date Apr 1, 2004
- Jose Luis Castro Pineiro
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclohexane derivatives and their use as therapeutic agents
- Publication number 20030236250
- Publication date Dec 25, 2003
- Jose Luis Castro Pineiro
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Cyclohexyl derivatives and their use as therapeutic agents
- Publication number 20030225059
- Publication date Dec 4, 2003
- Jose Luis Castro Pineiro
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Tetrahydrofuran derivatives and their use as nk-1 antagonists
- Publication number 20030199500
- Publication date Oct 23, 2003
- Brian John Williams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Tetrahydropyran derivatives and their use as therapeutic agents
- Publication number 20020035132
- Publication date Mar 21, 2002
- Jose Luis Castro Pineiro
- C07 - ORGANIC CHEMISTRY

Christopher John Swain

Person

Patents Grantslast 30 patents

Tetrahydropyran compounds as tachykinin antagonists

Gem-disubstituted cyclohexane derivatives and their use as therapeu...

Cyclohexane derivatives and their use as therapeutic agents

Tetrahydrofuran derivatives and their use as NK-1 antagonists

Cyclohexyl derivatives and their use as therapeutic agents

Tetrahydropyran derivatives as neurokinin receptor antagonists

Use of NK-1 receptor antagonists for treating major depressive diso...

Tetrahydropyran derivatives and their use as therapeutic agents

Tetrahydropyran derivatives and their use as therapeutic agents

Use of NK-1 receptor antagonists for treating cognitive disorders

Spiro-azacyclic derivatives and their use as therapeutic agents

Spiro-azacyclic derivatives and their use as therapeutic agents

1-piperidinyl-propan-2-derivatives and their use as therapeutic agents

Spiro-ketal derivatives and their use as therapeutic agents

Use of NK-1 receptor antagonists for treating major depressive diso...

Use of NK-1 receptors antagonists for treating schizophrenic disorders

3-benzylaminopiperidines as tachykinin receptor antagonists

Use of NK-1 receptor antagonists for treating amnestic disorders

Use of NK-1 receptor antagonists for treating stress disorders

Spiro-ketal derivatives and their use as therapeutic agents

Spiro-piperidine derivatives and their use as therapeutic agents

Spiro-piperidine derivatives and their use as therapeutic agents

Spiro-piperidine derivatives and their use as tachykinin antagonists

Spiro-azacyclic derivatives, their preparation and their use as tac...

Substituted morpholine derivative and its use as a therapeutic agent

Piperidine and morpholine derivatives and their use as therapeutic...

Use of NK-1 receptor antagonists for treating bipolar disorders

Morpholine derivatives and their use as therapeutic agents

Use of NK-1 receptor antagonists for treating bipolar disorders

Use of NK-1 receptor antagonists for treating sexual dysfunctions

Patents Applicationslast 30 patents

Tetrahydropyran compounds as tachykinin antagonists

Gem-disubstituted cyclohexane derivatives and their use as therapeu...

Tetrahydropyran derivatives as neurokinin receptor antagonists

Cyclohexane derivatives and their use as therapeutic agents

Cyclohexyl derivatives and their use as therapeutic agents

Tetrahydrofuran derivatives and their use as nk-1 antagonists

Tetrahydropyran derivatives and their use as therapeutic agents